Filing Details

Accession Number:
0001209191-15-041252
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-05-11 17:34:25
Reporting Period:
2015-05-04
Filing Date:
2015-05-11
Accepted Time:
2015-05-11 17:34:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1088856 Corcept Therapeutics Inc CORT Pharmaceutical Preparations (2834) 770487658
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1236387 N James Wilson C/O Corcept Therapeutics
149 Commonwealth Drive
Menlo Park CA 94025
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-05-04 10,000 $1.51 1,711,396 No 4 M Direct
Common Stock Disposition 2015-05-04 10,000 $5.92 1,701,396 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock option Disposition 2015-05-04 10,000 $0.00 10,000 $1.51
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
230,000 2017-05-18 No 4 M Direct
Footnotes
  1. Represents the weighted average sale price for the entire number of shares sold. The sale prices ranged from $5.85 to $6.01 per share.
  2. Fully exercisable